Identifying Novel Sepsis Subphenotypes Using Temperature Trajectories

Sepsis is a heterogeneous syndrome, and identifying clinically relevant subphenotypes is essential. To identify novel subphenotypes in hospitalized patients with infection using longitudinal temperature trajectories. In the model development cohort, inpatient admissions meeting criteria for infectio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of respiratory and critical care medicine 2019-08, Vol.200 (3), p.327-335
Hauptverfasser: Bhavani, Sivasubramanium V, Carey, Kyle A, Gilbert, Emily R, Afshar, Majid, Verhoef, Philip A, Churpek, Matthew M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Sepsis is a heterogeneous syndrome, and identifying clinically relevant subphenotypes is essential. To identify novel subphenotypes in hospitalized patients with infection using longitudinal temperature trajectories. In the model development cohort, inpatient admissions meeting criteria for infection in the emergency department and receiving antibiotics within 24 hours of presentation were included. Temperature measurements within the first 72 hours were compared between survivors and nonsurvivors. Group-based trajectory modeling was performed to identify temperature trajectory groups, and patient characteristics and outcomes were compared between the groups. The model was then externally validated at a second hospital using the same inclusion criteria. A total of 12,413 admissions were included in the development cohort, and 19,053 were included in the validation cohort. In the development cohort, four temperature trajectory groups were identified: "hyperthermic, slow resolvers" (  = 1,855; 14.9% of the cohort); "hyperthermic, fast resolvers" (  = 2,877; 23.2%); "normothermic" (  = 4,067; 32.8%); and "hypothermic" (  = 3,614; 29.1%). The hypothermic subjects were the oldest and had the most comorbidities, the lowest levels of inflammatory markers, and the highest in-hospital mortality rate (9.5%). The hyperthermic, slow resolvers were the youngest and had the fewest comorbidities, the highest levels of inflammatory markers, and a mortality rate of 5.1%. The hyperthermic, fast resolvers had the lowest mortality rate (2.9%). Similar trajectory groups, patient characteristics, and outcomes were found in the validation cohort. We identified and validated four novel subphenotypes of patients with infection, with significant variability in inflammatory markers and outcomes.
ISSN:1073-449X
1535-4970
DOI:10.1164/rccm.201806-1197OC